Find Trimegestone manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 74513-62-5, Ru 27987, Ru-27987, 4658k0h08w, Trimegestone [inn], Totelle sekvens, ondeva
Molecular Formula
C22H30O3
Molecular Weight
342.5  g/mol
InChI Key
JUNDJWOLDSCTFK-MTZCLOFQSA-N
FDA UNII
4658K0H08W

Trimegestone
Trimegestone has been used in trials studying the treatment of Postmenopause.
1 2D Structure

Trimegestone

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(8S,13S,14S,17S)-17-[(2S)-2-hydroxypropanoyl]-13,17-dimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one
2.1.2 InChI
InChI=1S/C22H30O3/c1-13(23)20(25)22(3)11-9-19-18-6-4-14-12-15(24)5-7-16(14)17(18)8-10-21(19,22)2/h12-13,18-19,23H,4-11H2,1-3H3/t13-,18+,19-,21-,22+/m0/s1
2.1.3 InChI Key
JUNDJWOLDSCTFK-MTZCLOFQSA-N
2.1.4 Canonical SMILES
CC(C(=O)C1(CCC2C1(CCC3=C4CCC(=O)C=C4CCC23)C)C)O
2.1.5 Isomeric SMILES
C[C@@H](C(=O)[C@]1(CC[C@@H]2[C@@]1(CCC3=C4CCC(=O)C=C4CC[C@@H]23)C)C)O
2.2 Other Identifiers
2.2.1 UNII
4658K0H08W
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 17-(2-hydroxy-1-oxopropyl)-17-methylestra-4,9-dien-3-one

2. 21-hydroxypromegestone

3. Ru 27987

4. Ru 27988

5. Ru-27987

6. Ru-27988

7. Trimegestone, (17beta(r))-isomer

2.3.2 Depositor-Supplied Synonyms

1. 74513-62-5

2. Ru 27987

3. Ru-27987

4. 4658k0h08w

5. Trimegestone [inn]

6. Totelle Sekvens, Ondeva

7. Ondeva

8. Trimegestone [usan:inn:ban]

9. Unii-4658k0h08w

10. (8s,13s,14s,17s)-17-[(2s)-2-hydroxypropanoyl]-13,17-dimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one

11. Trimegestone (usan/inn)

12. Trimegestone [usan]

13. Trimegestone [mart.]

14. Schembl518768

15. Trimegestone [who-dd]

16. Chembl2104765

17. Chebi:136027

18. Dtxsid201317995

19. Zinc4217604

20. Akos015967450

21. At35938

22. Db13129

23. Ac-24967

24. D06235

25. 513t625

26. A838156

27. Q7842164

28. 17beta-(s)-lactoyl-17-methylestra-4,9-dien-3-one

29. 17.beta.-(s)-lactoyl-17-methylestra-4,9-dien-3-one

30. Estra-4,9-dien-3-one, 17-(2-hydroxy-1-oxopropyl)-17-methyl-, (17.beta.(s))-

31. Estra-4,9-dien-3-one, 17-(2-hydroxy-1-oxopropyl)-17-methyl-, (17beta(s))-

2.4 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 342.5 g/mol
Molecular Formula C22H30O3
XLogP32.6
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count3
Rotatable Bond Count2
Exact Mass342.21949481 g/mol
Monoisotopic Mass342.21949481 g/mol
Topological Polar Surface Area54.4 Ų
Heavy Atom Count25
Formal Charge0
Complexity700
Isotope Atom Count0
Defined Atom Stereocenter Count5
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

Market Place

Do you need sourcing support? Ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty